Latest News and Press Releases
Want to stay updated on the latest news?
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Lund, Sweden, June 3, 2014 - Active Biotech...
-
Jerusalem & Lund, Sweden, May 23, 2014 - Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI) announced today that the Committee for Medicinal Products...
-
JERUSALEM, Israel & LUND, Sverige, den 23 maj, 2014 - Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) och Active Biotech (NASDAQ OMX NORDIC: ACTI) meddelar idag att det europeiska...
-
LUND, Sweden, May 16, 2014 (GLOBE NEWSWIRE) -- The Annual General Meeting of Active Biotech was held on May 15, 2014. In accordance with the Board of Directors' proposal, it was resolved that no...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Active Biotechs årsstämma hölls den 15 maj 2014....
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} The Annual General Meeting of Active Biotech was...
-
LUND, Sweden, April 24, 2014 (GLOBE NEWSWIRE) -- Laquinimod On January 24, the laquinimod (Nerventra®) market application received a negative opinion by the Committee for Medicinal...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Laquinimod On January 24, the laquinimod...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Laquinimod Laquinimod (Nerventra®)...
-
LUND, Sweden, April 14, 2014 (GLOBE NEWSWIRE) -- The Board of Directors of Active Biotech AB (publ) has issued a notice to the Annual General Meeting, which is to take place at 5 p.m. on Thursday, May...